Zenas Biopharma (usa), Llc
Clinical trials sponsored by Zenas Biopharma (usa), Llc, explained in plain language.
-
New hope for progressive MS: drug trial targets disability
Disease control Recruiting nowThis study tests an experimental drug called orelabrutinib against a placebo in people with primary progressive multiple sclerosis (PPMS), a form of MS that steadily worsens over time. The goal is to see if the drug can delay or prevent disability progression, such as walking or …
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New pill aims to slow MS progression in 990-patient global trial
Disease control Recruiting nowThis study tests an oral drug called orelabrutinib against a placebo in about 990 adults aged 18-60 with non-active secondary progressive multiple sclerosis (SPMS). The goal is to see if the drug can delay worsening disability over 12 to 60 months. Participants are randomly assig…
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated May 06, 2026 16:14 UTC